Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU

Annals of Intensive Care

Volumn 2, Issue 1, 2012, Pages

  Rayner, Samuel G ^a   Weinert, Craig R ^b   Peng, Helen ^c   Jepsen, Stacy ^c   Broccard, Alain F ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c FAIRVIEW SOUTHDALE HOSPITAL   (United States)

Author keywords

Alcohol withdrawal delirium; Alcohol withdrawal syndrome; Benzodiazepines; Critical care; Dexmedetomidine; Intensive care

Indexed keywords

DEXMEDETOMIDINE; HALOPERIDOL; LORAZEPAM;

ADJUVANT THERAPY; ADULT; ALCOHOL WITHDRAWAL; ARTICLE; ASYSTOLE; BRADYCARDIA; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HEART RATE; HUMAN; HYPOTENSION; INTENSIVE CARE; INTUBATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

EID: 84864230673     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-2-12     Document Type: Article

References (41)

1. O'Connor PG, Schottenfeld RS: Medical progress: patients with alcohol problems. N Engl J Med 1998, 338:592-602.
2. de Wit M, Jones DG, Sessler CN, Zilberberg MD, Weaver MF: Alcohol-use disorders in the critically ill patient. Chest 2010, 138:994-1003.
3. Hall W, Zador D: The alcohol withdrawal syndrome. Lancet 1997, 349:1897-1900.
4. Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J: Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004, 164:1405-1412.
5. Mayo-Smith MF: Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. J Am Med Assoc 1997, 278:144-151.
6. Kumar S, Porcu P, Werner DF, Matthews DB, Diaz-Granados JL, Helfand RS, Morrow LA: Ethanol: a decade of progress. Psychopharmacol 2010, 205:1-54.
7. Adinoff B: The alcohol withdrawal syndrome: neurobiology of treatment and toxicity. Am J Addict 1994, 3:277-288.
8. Tsai G, Gastfriend DR, Coyle JT: The glutamatergic basis of human alcoholism. Am J Psychiatr 1995, 152:332.
9. Heinz A, Schmidt K, Baum SS, Kuhn S, Dufeu P, Schmidt LG, Rommelspacher H: Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. J Stud Alcohol 1996, 57:471.
10. Agartz I, Shoaf S, Rawlings RR, Momenan R, Hommer DW: CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Psychiatr Res 2003, 122:21-35.
11. Holbrook AM, Crowther R, Lotter A, Cheng C, King D: Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. Can Med Assoc J 1999, 160:649-655.
12. Amato L, Minozzi S, Vecchi S, Davoli M: Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Rev 2010, 3:CD005063.
13. Al-Sanouri I, Dikin M, Soubani AO: Critical care aspects of alcohol abuse. South Med J 2005, 98:372-381.
14. Liesching T: Acute applications of noninvasive positive pressure ventilation. Chest 2003, 124:699-713.
15. Kosten TR, O'Connor PG: Management of drug and alcohol withdrawal. N Engl J Med 2003, 348:1786-1795.
16. Minozzi S, Amato L, Vecchi S, Davoli M: Anticonvulsants for alcohol withdrawal. Cochrane Database of Systematic Rev 2010, 3:CD005064.
17. Muzyk AJ, Fowler JA, Norwood DK, Chilipko A: Role of α2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother 2011, 45:649-657.
18. McCowan C, Marik P: Refractory delirium tremens treated with propofol: a case series. Crit Care Med 2000, 28:1781-1784.
19. Coomes TR, Smith SW: Successful use of propofol in refractory delirium tremens. Ann Emerg Med 1997, 30:825-828.
20. Gerlach AT, Murphy CV, Dasta JF: An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009, 43:2064-2074.
21. Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010, 36:926-939.
22. Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A: Treatment of ethanol withdrawal symptoms in the rat. Brain Res 1997, 21:804-808.
23. Riihioja P, Jaatinen P, Haapalinna A, Kiianmaa K, Hervonen A: Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure. Alcohol Clin Exp Res 1999, 23:432-438.
24. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R: Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatr 2006, 28:362-363.
25. Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber D: Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008, 42:1703-1705.
26. Maccioli GA: Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003, 98:575-577.
27. Baddigam K, Russo P, Russo J, Tobias J: Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005, 20:118-123.
28. Watling S, Fleming C, Casey P, Yanos J: Nursing-based protocol for treatment of alcohol withdrawal in the intensive care unit. Am J Crit Care 1995, 4:66-70.
29. Barash PG, Cullen BF, Stoelting RK, Calahan MK, Stock CM: Handbook of Clinical Anesthesia. Philadelphia: Lippincott Williams & Wilkins; 2009.
30. Jaatinen P, Riihioja P, Haapalinna A, Heinonen E, Kiianmaa K, Hervonen A: Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine. Alcohol 1995, 12:439-446.
31. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000, 4:302-308.
32. Venn RM, Grounds RM: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001, 87:684-690.
33. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000, 93:382-394.
34. Prommer E: Dexmedetomidine: does it have potential in palliative medicine? Am J Hosp Palliat Care 2010, 28:276-283.
35. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis B, Byrne D, Ely EW, Rocha MG: Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. J Am Med Assoc 2009, 301:489-499.
36. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard T, Miller R, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. J Am Med Assoc 2007, 298:2644-2653.
37. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie W, Bellomo R: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009, 13:R75.
38. Venn RM: Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002, 88:669-675.
39. Hoy SM, Keating GM: Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011, 71:1481-1501.
40. ®(dexmedetomidine hydrochloride injection). http://www.precedex.com
41. Robinson BJ, Robinson GM, Maling TJ, Johnson RH: Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exp Res 1989, 13:95-98.